Click here for more information about Indinavir sulfate [clinicaltrials_resource:64b5406116993ea7bf1346caf7a9aebe]
A Randomized Trial of L-735,524, An Inhibitor of the HIV Protease Enzyme, and Interleukin-2 in Persons Infected With HIV (NOTE: Only For Patients Who Previously Completed NIAID 93 CC-113) [clinicaltrials:NCT00000804]A Randomized Trial of the Efficacy and Safety of a Strategy of Starting With Nelfinavir Versus Ritonavir Added to Background Antiretroviral (AR) Nucleoside Therapy in HIV-Infected Individuals With CD4+ Cell Counts Less Than or Equal to 200/mm3 [clinicaltrials:NCT00000859]A Phase II Study of Intermittent Recombinant Human Interleukin-2 (rhIL-2) by Intravenous or Subcutaneous Administration in Subjects With HIV Infection on Highly Active Antiretroviral Therapy (HAART) Compared to HAART Alone [clinicaltrials:NCT00000870]Controlled Clinical Trial of Antiviral Cytotoxic T Lymphocyte (CTL) Infusion Following Combination Antiretroviral Drug Therapy for Asymptomatic HIV-1 Infection [clinicaltrials:NCT00000875]Study of How Indinavir (an Anti-HIV Drug) and Rifabutin (a Drug Used to Treat MAC, an HIV-Associated Disease) Interact in HIV-Positive and HIV-Negative Adults [clinicaltrials:NCT00000877]Virologic and Immunologic Activity of Continued Lamivudine (3TC) vs Delavirdine (DLV) in Combination With Indinavir (IDV) and Zidovudine (ZDV) or Stavudine (d4T) in 3TC-Experienced Subjects [clinicaltrials:NCT00000882]Treatment Success and Failure in HIV-Infected Subjects Receiving Indinavir in Combination With Nucleoside Analogs: A Rollover Study for ACTG 320 [clinicaltrials:NCT00000885]A Study to Compare the Effectiveness of a Four Drug Anti-HIV Regimen Given Alone or in Combination With GM-CSF or IL-12 to HIV-Positive Patients [clinicaltrials:NCT00000896]Safety and Effectiveness of Giving Indinavir Plus Stavudine Plus Lamivudine to HIV-Infected Children [clinicaltrials:NCT00000901]Addition of Efavirenz or Nelfinavir to a Lamivudine/Zidovudine/Indinavir HIV Treatment Regimen [clinicaltrials:NCT00000903]A Study of the Effectiveness of Different Anti-HIV Treatments in HIV-Positive Individuals Who Have Been on a Protease Inhibitor-Containing Drug Regimen for at Least 16 Weeks [clinicaltrials:NCT00000914]A Study of the Safety and Effectiveness of Hydroxyurea in Patients on Potent Antiretroviral Therapy and Who Have Less Than 200 Copies/ml of HIV RNA in Their Blood [clinicaltrials:NCT00000916]A Study to Compare The Ability of Different Anti-HIV Drugs to Decrease Viral Load After Nelfinavir (an Anti-HIV Drug)Treatment Failure [clinicaltrials:NCT00000918]Treatment With Interleukin-2 (IL-2) Plus Combination Anti-HIV-Drug Therapy (HAART) for Patients Formerly in ACTG 328 [clinicaltrials:NCT00000923]A Comparison of Three Drug Combinations Containing Clarithromycin in the Treatment of Mycobacterium Avium Complex (MAC) Disease in Patients With AIDS [clinicaltrials:NCT00001058]Comparison of New Anti-HIV Drug Combinations in HIV-Infected Children Who Have Taken Anti-HIV Drugs [clinicaltrials:NCT00001083]A Study of Three Treatment Combinations Using Zidovudine Plus Lamivudine Plus Indinavir in HIV-Infected Patients [clinicaltrials:NCT00001084]A Study of Three Anti-HIV Drug Combinations in Patients Who Have Taken Amprenavir [clinicaltrials:NCT00001095]Drug Interactions of Amprenavir and Efavirenz, in Combination With a Second Protease Inhibitor, in HIV-Negative Volunteers [clinicaltrials:NCT00005762]Safety and Effectiveness of an Anti-HIV Drug Combination With and Without Hydroxyurea in Patients With Early HIV Infection [clinicaltrials:NCT00006339]Ritonavir and Indinavir in Children Failing Other Anti-HIV Treatment [clinicaltrials:NCT00012519]Depo-Medroxyprogesterone Acetate (DMPA, Depo-Provera) Use With Certain Anti-HIV Drugs in HIV-Infected Women [clinicaltrials:NCT00016601]Using Drug Levels and Drug Resistance Testing to Select Effective Anti-HIV Drug Combinations in Patients With Drug-resistant HIV [clinicaltrials:NCT00027339]
link [clinicaltrials_vocabulary:link]
Click here for more information about Indinavir sulfate [clinicaltrials_resource:64b5406116993ea7bf1346caf7a9aebe]
Bio2RDF identifier
64b5406116993ea7bf1346caf7a9aebe
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:64b5406116993ea7bf1346caf7a9aebe
url [clinicaltrials_vocabulary:url]
identifier
clinicaltrials_resource:64b5406116993ea7bf1346caf7a9aebe
title
Click here for more information about Indinavir sulfate
@en
type
label
Click here for more informatio ...... 5406116993ea7bf1346caf7a9aebe]
@en